Literature DB >> 22966265

Overexpression of neutrophil gelatinase-associated lipocalin and its receptor in colorectal carcinoma: Significant correlation with cell differentiation and tumour invasion.

Zhuo Lv1, Li-Yan Xu, Zhong-Ying Shen, Fa-Ren Zhang, Xiu-E Xu, En-Min Li.   

Abstract

Neutrophil gelatinase-associated lipocalin (NGAL), a member of the lipocalin family, is related to imflammation and tumour. Recently, a specific cell-surface receptor (24p3R/NGALR) for lipocalin 24p3 was reported. However, the characteristics of NGALR expression in colorectal carcinoma (CRC) are not known. The objectives of this study were to investigate the expression of NGAL and NGALR in CRC specimens, and determine any relationship between the expression of these proteins and tumour progression. In the present study, CRC specimens of 102 patients were obtained, and the expression of NGAL, NGALR, ferritin and Ki67 was analyzed in paraffin sections by immunohistochemistry. Statistical analyses of the data collected were performed with SPSS software. We found that the cytoplasmic staining of NGAL, NGALR and ferritin, as well as the nuclear staining of Ki67 were significantly up-regulated in CRC tissues compared with normal colorectal tissues. Expression of NGAL was related to the deeper invasion of CRC (P=0.026), while NGALR was significantly associated with a deeper invasion (P=0.018) and a high degree of Tumor, Node and Metastasis stages (P=0.042) in CRC. The NGAL/NGALR co-expression was associated with poor cellular differentiation (P=0.004). Positive correlations between NGAL and NGALR (r=0.432, P<0.01), NGAL and ferritin (r=0.374, P<0.001), NGALR and Ki67 (r=0.228, P<0.05), NGAL/NGALR co-expression and ferritin (r=0.349, P<0.001), as well as NGAL/NGALR co-expression and Ki67 (r=0.205, P<0.05) were observed. However, the expression of NGAL or NGALR was not significantly associated with patient survival. These findings detected an elevated expression of NGAL and NGALR resulting in poor cellular differentiation and a deeper invasion of CRC. Thus, NGALR may be a novel target for the treatment of CRC.

Entities:  

Year:  2010        PMID: 22966265      PMCID: PMC3436261          DOI: 10.3892/ol_00000019

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

1.  Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury.

Authors:  Kiyoshi Mori; H Thomas Lee; Dana Rapoport; Ian R Drexler; Kirk Foster; Jun Yang; Kai M Schmidt-Ott; Xia Chen; Jau Yi Li; Stacey Weiss; Jaya Mishra; Faisal H Cheema; Glenn Markowitz; Takayoshi Suganami; Kazutomo Sawai; Masashi Mukoyama; Cheryl Kunis; Vivette D'Agati; Prasad Devarajan; Jonathan Barasch
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

2.  Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression.

Authors:  T Koshiba; R Hosotani; Y Miyamoto; J Ida; S Tsuji; S Nakajima; M Kawaguchi; H Kobayashi; R Doi; T Hori; N Fujii; M Imamura
Journal:  Clin Cancer Res       Date:  2000-09       Impact factor: 12.531

3.  Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method.

Authors:  M Furutani; S Arii; M Mizumoto; M Kato; M Imamura
Journal:  Cancer Lett       Date:  1998-01-09       Impact factor: 8.679

4.  Decrease of manganese superoxide dismutase activity in rats fed high levels of iron during colon carcinogenesis.

Authors:  C N Kuratko
Journal:  Food Chem Toxicol       Date:  1998 Sep-Oct       Impact factor: 6.023

5.  An iron delivery pathway mediated by a lipocalin.

Authors:  Jun Yang; David Goetz; Jau Yi Li; Wenge Wang; Kiyoshi Mori; Daria Setlik; Tonggong Du; Hediye Erdjument-Bromage; Paul Tempst; Roland Strong; Jonathan Barasch
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

6.  Iron intake and the risk of colorectal cancer.

Authors:  J I Wurzelmann; A Silver; D M Schreinemachers; R S Sandler; R B Everson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1996-07       Impact factor: 4.254

Review 7.  Iron, lipocalin, and kidney epithelia.

Authors:  Jun Yang; Kiyoshi Mori; Jau Yi Li; Jonathan Barasch
Journal:  Am J Physiol Renal Physiol       Date:  2003-07

8.  RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.

Authors:  Allison P Armstrong; Robert E Miller; Jon C Jones; Jian Zhang; Evan T Keller; William C Dougall
Journal:  Prostate       Date:  2008-01-01       Impact factor: 4.104

9.  Cloning and expression of human neutrophil lipocalin cDNA derived from bone marrow and ovarian cancer cells.

Authors:  S Bartsch; H Tschesche
Journal:  FEBS Lett       Date:  1995-01-09       Impact factor: 4.124

10.  Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion.

Authors:  Haihua Zhang; Liyan Xu; Dawei Xiao; Jianjun Xie; Hongmei Zeng; Zhaoyang Wang; Xiaoling Zhang; Yongdong Niu; Zhongying Shen; Jinghui Shen; Xuan Wu; Enmin Li
Journal:  J Clin Pathol       Date:  2007-04-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.